Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	111	86	40	112	100	160
Market Cap Growth	105.98%	118.11%	-64.73%	12.29%	-37.55%	48.85%
Enterprise Value	90	61	-0	46	58	85
PE Ratio	-	-3.19	-0.96	-2.59	-16.66	-3.43
PB Ratio	3.34	2.23	0.71	1.16	1.39	2.25
P/FCF Ratio	-4.16	-3.60	-1.45	-3.06	-2.87	-4.28
P/OCF Ratio	-4.16	-3.61	-1.46	-3.06	-2.87	-4.29
EV/EBITDA Ratio	-2.68	-2.25	0.00	-1.08	-10.81	-1.85
EV/EBIT Ratio	-2.66	-2.24	0.00	-1.07	-9.67	-1.82
EV/FCF Ratio	-3.16	-2.53	0.00	-1.26	-1.66	-2.28
Debt / Equity Ratio	0.03	0.04	0.05	0.04	0.03	0.04
Debt / EBITDA Ratio	-0.04	-0.05	-0.06	-0.09	-0.43	-0.07
Debt / FCF Ratio	-0.05	-0.06	-0.10	-0.10	-0.07	-0.09
Quick Ratio	3.30	3.96	3.99	7.22	3.64	7.63
Current Ratio	3.40	4.07	4.06	7.36	3.73	7.76
Return on Equity (ROE)	-60.00%	-59.60%	-56.80%	-44.00%	-10.60%	-54.60%
Return on Assets (ROA)	-50.80%	-50.60%	-48.30%	-38.70%	-8.60%	-47.70%
Return on Capital (ROIC)	-67.10%	-58.43%	-55.42%	-38.32%	-58.77%	-65.75%
Earnings Yield	-22.33%	-31.32%	-104.39%	-38.55%	-6.00%	-29.18%
FCF Yield	-18.84%	-27.77%	-68.92%	-32.73%	-34.89%	-23.35%
Buyback Yield / Dilution	-5.33%	-3.16%	-11.23%	-41.98%	-0.44%	-6.69%
Total Shareholder Return	-5.33%	-3.16%	-11.23%	-41.98%	-0.44%	-6.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).